Logo image of HSII

HEIDRICK & STRUGGLES INTL (HSII) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HSII - US4228191023 - Common Stock

58.97 USD
+0.03 (+0.05%)
Last: 12/5/2025, 8:26:27 PM
58.97 USD
0 (0%)
After Hours: 12/5/2025, 8:26:27 PM
Fundamental Rating

5

Overall HSII gets a fundamental rating of 5 out of 10. We evaluated HSII against 87 industry peers in the Professional Services industry. Both the profitability and the financial health of HSII get a neutral evaluation. Nothing too spectacular is happening here. HSII has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HSII was profitable.
In the past year HSII had a positive cash flow from operations.
HSII had positive earnings in 4 of the past 5 years.
Of the past 5 years HSII 4 years had a positive operating cash flow.
HSII Yearly Net Income VS EBIT VS OCF VS FCFHSII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

HSII has a Return On Assets of 2.93%. This is comparable to the rest of the industry: HSII outperforms 51.72% of its industry peers.
The Return On Equity of HSII (7.28%) is comparable to the rest of the industry.
HSII's Return On Invested Capital of 8.74% is fine compared to the rest of the industry. HSII outperforms 60.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HSII is in line with the industry average of 12.17%.
Industry RankSector Rank
ROA 2.93%
ROE 7.28%
ROIC 8.74%
ROA(3y)4.09%
ROA(5y)2.81%
ROE(3y)11.02%
ROE(5y)8.12%
ROIC(3y)10.87%
ROIC(5y)11.02%
HSII Yearly ROA, ROE, ROICHSII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

HSII's Profit Margin of 3.04% is in line compared to the rest of the industry. HSII outperforms 54.02% of its industry peers.
HSII's Profit Margin has declined in the last couple of years.
HSII's Operating Margin of 6.59% is in line compared to the rest of the industry. HSII outperforms 56.32% of its industry peers.
In the last couple of years the Operating Margin of HSII has declined.
Looking at the Gross Margin, with a value of 87.57%, HSII belongs to the top of the industry, outperforming 95.40% of the companies in the same industry.
HSII's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.59%
PM (TTM) 3.04%
GM 87.57%
OM growth 3Y-13.17%
OM growth 5Y-6.58%
PM growth 3Y-52.28%
PM growth 5Y-34.45%
GM growth 3Y-2.32%
GM growth 5Y-2.06%
HSII Yearly Profit, Operating, Gross MarginsHSII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HSII is creating some value.
HSII has more shares outstanding than it did 1 year ago.
HSII has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HSII. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HSII Yearly Shares OutstandingHSII Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HSII Yearly Total Debt VS Total AssetsHSII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.69 indicates that HSII is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HSII (2.69) is comparable to the rest of the industry.
HSII has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.69
ROIC/WACC1
WACC8.75%
HSII Yearly LT Debt VS Equity VS FCFHSII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

HSII has a Current Ratio of 1.53. This is a normal value and indicates that HSII is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HSII (1.53) is comparable to the rest of the industry.
HSII has a Quick Ratio of 1.53. This is a normal value and indicates that HSII is financially healthy and should not expect problems in meeting its short term obligations.
HSII has a Quick ratio of 1.53. This is comparable to the rest of the industry: HSII outperforms 55.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
HSII Yearly Current Assets VS Current LiabilitesHSII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

HSII shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.38%, which is quite impressive.
HSII shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.93% yearly.
HSII shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.53%.
HSII shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)23.38%
EPS 3Y-7.75%
EPS 5Y3.93%
EPS Q2Q%15.28%
Revenue 1Y (TTM)11.53%
Revenue growth 3Y3.42%
Revenue growth 5Y8.99%
Sales Q2Q%15.94%

3.2 Future

The Earnings Per Share is expected to grow by 6.13% on average over the next years.
HSII is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.20% yearly.
EPS Next Y-2.87%
EPS Next 2Y6.88%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue Next Year10.47%
Revenue Next 2Y5.83%
Revenue Next 3Y6.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSII Yearly Revenue VS EstimatesHSII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
HSII Yearly EPS VS EstimatesHSII Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.19, the valuation of HSII can be described as rather expensive.
Based on the Price/Earnings ratio, HSII is valued a bit cheaper than the industry average as 64.37% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.46. HSII is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 16.44, the valuation of HSII can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSII indicates a somewhat cheap valuation: HSII is cheaper than 60.92% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HSII to the average of the S&P500 Index (36.10), we can say HSII is valued rather cheaply.
Industry RankSector Rank
PE 17.19
Fwd PE 16.44
HSII Price Earnings VS Forward Price EarningsHSII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

88.51% of the companies in the same industry are more expensive than HSII, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HSII indicates a rather cheap valuation: HSII is cheaper than 87.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.26
EV/EBITDA 6.2
HSII Per share dataHSII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)4.38
EPS Next 2Y6.88%
EPS Next 3Y6.13%

6

5. Dividend

5.1 Amount

HSII has a Yearly Dividend Yield of 1.02%. Purely for dividend investing, there may be better candidates out there.
HSII's Dividend Yield is a higher than the industry average which is at 4.07.
With a Dividend Yield of 1.02, HSII pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

The dividend of HSII has a limited annual growth rate of 0.64%.
HSII has been paying a dividend for at least 10 years, so it has a reliable track record.
HSII has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.64%
Div Incr Years0
Div Non Decr Years11
HSII Yearly Dividends per shareHSII Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

HSII pays out 35.14% of its income as dividend. This is a sustainable payout ratio.
HSII's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.14%
EPS Next 2Y6.88%
EPS Next 3Y6.13%
HSII Yearly Income VS Free CF VS DividendHSII Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
HSII Dividend Payout.HSII Dividend Payout, showing the Payout Ratio.HSII Dividend Payout.PayoutRetained Earnings

HEIDRICK & STRUGGLES INTL

NASDAQ:HSII (12/5/2025, 8:26:27 PM)

After market: 58.97 0 (0%)

58.97

+0.03 (+0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)03-02 2026-03-02/amc
Inst Owners97.45%
Inst Owner Change0.09%
Ins Owners1.47%
Ins Owner Change0.09%
Market Cap1.23B
Revenue(TTM)1.22B
Net Income(TTM)37.05M
Analysts45.71
Price Target60.18 (2.05%)
Short Float %2.53%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0.64
Dividend Growth(5Y)0.64%
DP35.14%
Div Incr Years0
Div Non Decr Years11
Ex-Date11-13 2025-11-13 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.1%
Min EPS beat(2)7.07%
Max EPS beat(2)13.12%
EPS beat(4)3
Avg EPS beat(4)21.68%
Min EPS beat(4)-2.45%
Max EPS beat(4)68.96%
EPS beat(8)7
Avg EPS beat(8)15.42%
EPS beat(12)10
Avg EPS beat(12)13.71%
EPS beat(16)13
Avg EPS beat(16)13.68%
Revenue beat(2)2
Avg Revenue beat(2)5.17%
Min Revenue beat(2)4.75%
Max Revenue beat(2)5.59%
Revenue beat(4)4
Avg Revenue beat(4)4.94%
Min Revenue beat(4)4.61%
Max Revenue beat(4)5.59%
Revenue beat(8)8
Avg Revenue beat(8)3.68%
Revenue beat(12)11
Avg Revenue beat(12)2.99%
Revenue beat(16)13
Avg Revenue beat(16)2.7%
PT rev (1m)0%
PT rev (3m)13.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.46%
Revenue NQ rev (1m)1.19%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 17.19
Fwd PE 16.44
P/S 1.01
P/FCF 9.26
P/OCF 7.6
P/B 2.41
P/tB 3.43
EV/EBITDA 6.2
EPS(TTM)3.43
EY5.82%
EPS(NY)3.59
Fwd EY6.08%
FCF(TTM)6.37
FCFY10.8%
OCF(TTM)7.76
OCFY13.15%
SpS58.59
BVpS24.49
TBVpS17.21
PEG (NY)N/A
PEG (5Y)4.38
Graham Number43.48
Profitability
Industry RankSector Rank
ROA 2.93%
ROE 7.28%
ROCE 11.06%
ROIC 8.74%
ROICexc 32.14%
ROICexgc 138.41%
OM 6.59%
PM (TTM) 3.04%
GM 87.57%
FCFM 10.87%
ROA(3y)4.09%
ROA(5y)2.81%
ROE(3y)11.02%
ROE(5y)8.12%
ROIC(3y)10.87%
ROIC(5y)11.02%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.76%
ROCE(5y)13.95%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-49.09%
ROICexc growth 5Y4.22%
OM growth 3Y-13.17%
OM growth 5Y-6.58%
PM growth 3Y-52.28%
PM growth 5Y-34.45%
GM growth 3Y-2.32%
GM growth 5Y-2.06%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 140.86%
Cap/Sales 2.37%
Interest Coverage 250
Cash Conversion 160.16%
Profit Quality 357.48%
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 2.69
F-Score5
WACC8.75%
ROIC/WACC1
Cap/Depr(3y)105.62%
Cap/Depr(5y)75.16%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3Y-7.75%
EPS 5Y3.93%
EPS Q2Q%15.28%
EPS Next Y-2.87%
EPS Next 2Y6.88%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue 1Y (TTM)11.53%
Revenue growth 3Y3.42%
Revenue growth 5Y8.99%
Sales Q2Q%15.94%
Revenue Next Year10.47%
Revenue Next 2Y5.83%
Revenue Next 3Y6.2%
Revenue Next 5YN/A
EBIT growth 1Y5.29%
EBIT growth 3Y-10.2%
EBIT growth 5Y1.81%
EBIT Next Year95.07%
EBIT Next 3Y30.7%
EBIT Next 5YN/A
FCF growth 1Y503.79%
FCF growth 3Y-22.36%
FCF growth 5Y10.54%
OCF growth 1Y894.35%
OCF growth 3Y-17.86%
OCF growth 5Y13.86%

HEIDRICK & STRUGGLES INTL / HSII FAQ

What is the fundamental rating for HSII stock?

ChartMill assigns a fundamental rating of 5 / 10 to HSII.


What is the valuation status for HSII stock?

ChartMill assigns a valuation rating of 5 / 10 to HEIDRICK & STRUGGLES INTL (HSII). This can be considered as Fairly Valued.


What is the profitability of HSII stock?

HEIDRICK & STRUGGLES INTL (HSII) has a profitability rating of 4 / 10.


Can you provide the financial health for HSII stock?

The financial health rating of HEIDRICK & STRUGGLES INTL (HSII) is 6 / 10.


Can you provide the expected EPS growth for HSII stock?

The Earnings per Share (EPS) of HEIDRICK & STRUGGLES INTL (HSII) is expected to decline by -2.87% in the next year.